MedNous

Experts says size matters in defining nanomedicine

Thursday 2 September 2010

Country: United Kingdom

In the realm of nanotechnology, size matters. But exactly what is meant by ‘nanoscale’ and ‘nanomedicine’ is still open for discussion. This was one of the themes to emerge from the first day of a two-day workshop on nanotechnology which is being hosted by the European Medicines Agency in London.

Scientists from 27 countries, including the US and Japan, were on hand on 2 September 2010 to discuss the key features of nanomedicines and the challenges that they pose to pharmaceutical regulation.

The EMA’s Patrick Le Courtois opened the meeting by explaining that the regulatory community is eager to “hear and understand” the latest nanotechnology science.

The European Commission has defined nanomedicine as the applicatio